| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9377898 | Biological Psychiatry | 2005 | 7 Pages |
Abstract
This study supports the validity of ketamine as a pharmacological model of schizophrenia. Based on the known pharmacological effects of ketamine, further studies should allow the investigation of the pharmacological basis of distractibility.
Related Topics
Life Sciences
Neuroscience
Biological Psychiatry
Authors
Carine Condy, Nicolas Wattiez, Sophie Rivaud-Péchoux, Bertrand Gaymard,